Atai Beckley Inc.
NASDAQ:ATAIBiotechnology
-$0.06 today
- Market cap
- $2.72B
- Beta
- 1.60
- P/E (TTM)
- -1.4
- EPS (TTM)
- -$2.93
Volume 0.00M
Average 5.68M
ATAI Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
Atai Beckley Inc.NASDAQ: ATAI
Accounts Payables · Q2 FY2026 · quarter ended Jun 2026
Accounts payables dips below year-ago levels
Q2 FY2026 accounts payables of $766.12K fell 1.4% year over year, behind the +1469.1% change in trailing-twelve-month accounts payables. Sequentially, it fell 87.1% from the prior quarter. Over 3 fiscal years it compounded at -17.6% a year.
Context
- Accounts payables amounted to 41.5% of revenue in FY2025, down 566.3 pp from a year earlier.
- Accounts payables increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -1.4% toward the trailing-twelve-month pace of +1469.1%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- (1.7M) USD
- Year-over-year change
- +9.5%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (1.7M) | +9.5% |
| FY2024 | 2024-12-31 | (1.87M) | -187.6% |
| FY2023 | 2023-12-31 | 2.14M | +170.5% |
| FY2022 | 2022-12-31 | (3.03M) | -231.9% |
| FY2021 | 2021-12-31 | 2.3M | — |
Accounts Payables vs competitors
How ATAI compares with its peers on the latest reported figures
- Peers report in different currencies, so accounts payables is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +1469.1% is the highest of 11, against a peer median of -5.3%.
- Accounts payables amounts to 90.4% of revenue for ATAI, versus a peer median of 25.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | €11.74M EUR | -29.4% | — | 31.5% | |
| LTM Jun 2026 | $10.61M USD | +20.3% | — | 19.4% | |
| LTM Jun 2026 | $9.69M USD | +1.8% | +70.4% | 508.8% | |
| LTM Jun 2026 | $7.04M USD | -374.8% | — | 68.0% | |
| LTM Jun 2026 | $4.04M USD | +1469.1% | -17.6% | 90.4% | |
| LTM Sep 2026 | $1.56M USD | -12.3% | -32.1% | — | |
| LTM Sep 2026 | $1.4M USD | +348.4% | +25.7% | — | |
| LTM Mar 2026 | $1.13M USD | +163.5% | — | — | |
| LTM Mar 2026 | $796K USD | -35.7% | — | 0.4% | |
| LTM Mar 2026 | $448K USD | +36.6% | +70.0% | — | |
| LTM Mar 2026 | $130K USD | -101.0% | +67.3% | 10.0% | |
| Peer median (excluding ATAI) | — | -5.3% | +67.3% | 25.5% | |
Competitors are the stored peer set for ATAI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (174.24M) | (157.42M) | (43.9M) | (150.05M) | (660.05M) |
| Depreciation & Amortization | 47K | 168K | 319K | 473K | 1.01M |
| Deferred Income Tax | 39.14M | 5.07M | 0 | 0 | 0 |
| Stock-Based Compensation | 63.36M | 42.38M | 32.98M | 25.49M | 0 |
| Change in Working Capital | (7.6M) | (3.34M) | 7.47M | (9.2M) | (6.48M) |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 2.3M | (3.03M) | 2.14M | (1.87M) | (1.7M) |
| Other Working Capital | (9.9M) | (301K) | 5.33M | (7.33M) | (4.78M) |
| Other Non-Cash Items | 16.06M | 8.67M | (80.99M) | 50.85M | 562.84M |
| Operating Cash Flow | (63.25M) | (104.47M) | (84.12M) | (82.44M) | (102.68M) |
| Capital Expenditures | (1.13M) | (1.02M) | (590K) | (95K) | (901K) |
| Acquisitions (Net) | (52.94M) | 0 | (443K) | 359K | 4.64M |
| Purchases of Investments | (23.66M) | (309.66M) | (186.22M) | (15M) | (98.95M) |
| Sales of Investments | (955K) | 226.83M | 139.47M | 82.01M | 9.05M |
| Other Investing Activities | (2.6M) | (3.25M) | (5.84M) | (8.1M) | (13M) |
| Investing Cash Flow | (81.28M) | (86.85M) | (53.3M) | 59.17M | (109.13M) |
| Debt Repayment | 1.59M | 15M | 0 | 5M | 7.71M |
| Common Stock Issued | 409.88M | 0 | 0 | 535K | 283.43M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.42M | 5.19M | (8.36M) | (161K) | (21.66M) |
| Financing Cash Flow | 409.86M | 20.79M | (8.36M) | 5.37M | 269.48M |
| Effect of Forex Changes | (320K) | (1.12M) | 189K | 362K | 116K |
| Net Change in Cash | 265.02M | (171.65M) | (145.58M) | (17.53M) | 57.8M |
| Free Cash Flow | (64.37M) | (105.49M) | (84.71M) | (82.53M) | (103.58M) |
Atai Beckley Inc.
NASDAQ:ATAI
Intrinsic Alpha fair value
Locked
Current Price
$7.35
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.